Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion type Assertion NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_head.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion wasGeneratedBy ECO_0000203 NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_provenance.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion wasDerivedFrom befree-20140225 NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_provenance.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion SIO_000772 22021366 NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_provenance.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion evidence source_evidence_literature NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_provenance.
- NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_assertion description "[Altogether, our data suggest that AMPK is an attractive target for the treatment of BCR-ABL-expressing malignancies and raise the potential for use of AMPK activators in the treatment of refractory chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737580.RAe6VjJPICcuy1uQR4o76Uv7UWULlchCTNpmZ6Mmm0Y1k130_provenance.